Posted on May 9, 2019 by Sitemaster
The issue of spontaneous remission of low-risk forms of prostate cancer came up yesterday during a meeting of Prostate Cancer International’s Active Surveillance Virtual Support Group (ASVSG). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: cancer, incidence, prostate, regression, remission, research, spontaneous | 9 Comments »
Posted on April 23, 2019 by Sitemaster
Depression is relatively common among men with prostate cancer. Indeed, it may be a lot more common than we can currently document. … READ MORE …
Filed under: Uncategorized | Tagged: ADT, androgen, cancer, depression, deprivation, prostae, risk | 3 Comments »
Posted on April 15, 2019 by Sitemaster
In his latest epistle on living with cancer on MedPage Today, Howard Wolinsky addresses what he has come to understand is a very sensitive topic. … READ MORE …
Filed under: Uncategorized | Tagged: battle, cancer, fight, survivor, war, warrior | 5 Comments »
Posted on March 27, 2019 by Sitemaster
There is a constant stream of scientific papers that focus on the possible ways that prostate cancer may start to spread within the prostate and then elsewhere. … READ MORE …
Filed under: Uncategorized | Tagged: cancer, EN2, engrailed-2, microvesicle, spread | Leave a comment »
Posted on February 1, 2019 by Sitemaster
The Prostate Cancer Foundation (PCF) has just published the 2019 update to its Prostate Cancer Patient Guide, which is a very useful (and free) introduction to prostate cancer for patients and their caregivers. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: cancer, Foundation, guide, patient, PCF, prostate | Leave a comment »
Posted on January 7, 2019 by Sitemaster
An article just published in the journal Cancer states that — at least here in the USA — there was no significant increase in risk for suicide within the first year after diagnosis among men diagnosed with prostate cancer between 2000 and 2014 … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: cancer, Diagnosis, prostate, risk, suicide | 2 Comments »
Posted on January 4, 2019 by Sitemaster
Our regular readers will remember that we have commented on and off on the development of different types of system that (maybe) can be used to test for risk of cancer based on smell … an ability that has been clearly demonstrated among certain trained dogs and one of two electronic systems. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: breath, cancer, Diagnosis, risk, screening, smell | Leave a comment »
Posted on January 3, 2019 by Sitemaster
Two sets of results from a major trial focused on the use of supplements to prevent cancer and heart disease are published today in the New England Journal of Medicine. … READ MORE …
Filed under: Diagnosis, Prevention | Tagged: calciferol, cancer, disease, fatty acid, heart, marine n-3, omega-3, Prevention, vitamin D | 12 Comments »
Posted on December 6, 2018 by Sitemaster
By now, many readers have probably seen news reports coming out of Australia about the “possible medical breakthrough” of a rapid, highly accurate test that can be used to detect cancer anywhere in the body (prostate cancer specifically included). … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: cancer, DNA, methylation, Methylscape, test | 2 Comments »
Posted on December 4, 2018 by Sitemaster
This morning, Prostate Cancer International (PCaI) announced the appointment of Michael B. Williams, MD, as its Medical Director and as a member of the Board of Directors of the foundation. … READ MORE …
Filed under: About Us | Tagged: cancer, International, Krongrad, PCaI, prostate, Williams | 2 Comments »
Posted on November 1, 2018 by Sitemaster
We have probably all heard terms like “liquid biopsy” and “genetic screening” and “cell-free” DNA analysis over the past few years. These are all terms related to the use of genetic and genomic information to “personalize” cancer diagnosis and its management. And they are potentially a huge big deal. But, … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: analysis, cancer, detection, DNA, Management, monitoring, risk | 4 Comments »
Posted on September 14, 2018 by Sitemaster
Alicia Morgans, MD, MPH, is a medical oncologist who specializes in prostate cancer management at Northwestern University Feinberg School of Medicine in Chicago, Illinois, where she is an associate professor in the Division of Hematology/Oncology. She is also an editor of the Advanced Prostate Cancer Center of Excellence for the UroToday web site. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: awareness, cancer, Morgans, prostate | 14 Comments »
Posted on August 16, 2018 by Sitemaster
The answer to this question, some 70 to 80 years after we started to see if we could answer it, is still: “We haven’t got a clue.” But every so often people come up with a new or a revised hypothesis, and it can take years to work out whether each specific hypothesis is viable. … READ MORE …
Filed under: Uncategorized | Tagged: cancer, citrate, development, prolactin, prostate, testosterone, zinc | 4 Comments »
Posted on June 19, 2018 by Sitemaster
In a new article in the Journal of Urology, researchers at Johns Hopkins Medical Center in Baltimore have again expressed their opinion that it would be inappropriate to rename low-risk Gleason 6 disease as something other than “cancer”. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: cancer, IMPACT, not, opinion, terminology | 3 Comments »
Posted on May 15, 2018 by Sitemaster
“Getting off biopsy train in prostate cancer” is the title of the latest article by Howard Wolinsky (a long-time active active surveillance patient) on the MedPage Today web site. We recommend it to your attention. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk | Tagged: active, cancer, Diagnosis, Management, proactive, risk, surveillance | 13 Comments »